Bioiberica Achieves Collagen Verified™ Certification, Advancing Global Transparency Standards
The Collagen Stewardship Alliance is proud to recognize Bioiberica as the latest company to achieve the NutraStrong® Collagen Verified™ certification. This marks a significant step forward in our shared mission to raise the bar on quality, transparency, and integrity in the global collagen marketplace. This milestone reflects Bioiberica’s continued commitment to science-backed innovation, traceability, and responsible sourcing in the collagen space.
Bioiberica certified NutraStrong™ Collagen Verification
Spanish company Bioiberica, which is celebrating its 50th anniversary this year, is the first collagen producer to receive NutraStrong™ Collagen Verification certification from SGS Nutrasource. The certification covers native (undenatured) type II collagen, Collavant® n2, intended to support joint health at a dose of 40 mg/day.
In the increasingly saturated collagen market, this ‘label’ is intended to help brands differentiate their products containing Collavant® n2, which meets strict standards for purity, sourcing integrity, production and claim substantiation.
The NutraStrong™ Collagen Verified programme is the first independent certification system dedicated to assessing and verifying the identity, source, safety and quality of collagen ingredients and products – ensuring that consumers get what they see on the label. To be complete, certifications of this type have already been developed for omega-3 and probiotics. But never for collagen.
The NutraStrong™ Collagen Verified programme has been approved by the Collagen Stewardship Alliance (CSA).
‘As the first global brand to achieve Collagen Verified status – backed by the Collagen Stewardship Alliance – Bioiberica is raising industry standards for collagen quality and consumer confidence,’ said Kevin Yan, Vice President of Product Certifications at SGS Nutrasource.
Second Collagen Symposium at Vitafoods Europe
On the first day of Vitafoods Europe, Bioiberica hosted the second Collagen Symposium (the first edition took place in 2023). A round table brought together industry experts (Len Monheit, Executive Director of the Collagen Stewardship Alliance, Elizabeth Thundow, Vice President of Management Consulting at Kline & Company, David Foreman, pharmacist and natural health expert, and Daniel Martínez-Puig, Director of Research and Development in Human Health at Bioiberica).
During the symposium, many topics were discussed, including the latest scientific data, the different types of collagen (including plant-based collagen) and the main opportunities for innovation.
‘There is confusion in the collagen market,’ emphasised Monica Gomez Navarro, Branded Ingredients Marketing Manager at Bioiberica, during a discussion with Actif’s Mag at the Palafolls production site. ‘This confusion is prompting us to develop tools and data that will help demystify this raw material.’ She cited data from a 2024 survey of around 100 visitors to Vitafoods Europe. 84% of them knew that collagen is effective against joint problems. But half did not know what type of collagen is involved.
‘To solve this problem, we need to develop cooperation between market players, provide more scientific evidence and be transparent,’ concludes Monica Gomez Navarro, ‘in order to protect consumers.’
Branded ingredients
Collavant® n2 is a source of native (undenatured) type II collagen that promotes joint health at a convenient low dose of 40 mg/day.
Other active ingredients are based on hyaluronic acid: Dermial® (60 mg/day) for skin health, Mobilee® (80 mg/day) for joint and muscle support, and DAOgest (4.2 mg/serving) for histamine intolerance.
Half a century of innovation
« This year, we are celebrating 50 years of scientific expertise, sustainable progress and the production of world-class ingredients of biological origin. We have become the largest Western producer of heparin, while pioneering circular economy practices for over 45 years. Our passion for science, sustainability and progress will continue to fuel our development, » concludes Antonio Vendrell, Director of Marketing and Communications at Bioiberica.
About Bioiberica
Bioiberica produces APIs (including heparin (world leader), glucosamine and chondroitin) and ingredients for nutraceuticals at its site in Palafolls (north of Barcelona).
Raw materials are sourced from eight other units in Europe, the USA and Brazil.
Bioiberica is part of the vertically integrated German family-owned Saria Group, which has developed in the processing of raw materials of animal origin. The group employs 13,000 people and has a turnover of more than €3.4 billion.
